• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Innospec Inc. (Amendment)

    2/9/24 2:18:58 PM ET
    $IOSP
    Major Chemicals
    Industrials
    Get the next $IOSP alert in real time by email
    SC 13G/A 1 iosp224.txt SCHEDULE 13G Amendment No. 1 Name of Issuer: Innospec, Inc. Title of Class of Securities: Common Stock CUSIP Number: 45768S105 Item 1: Reporting Person: Wasatch Advisors LP 87-0319391 Item 2: Check Box If Member of Group: Not Applicable Item 3: SEC Use Item 4: Place of Organization: Utah Items 5-8: Number of Shares Owned With: Item 5: Sole Voting Power: 1,950,016 Item 6: Shared Voting Power: 0 Item 7: Sole Dispositive Power: 1,950,016 Item 8: Shared Dispositive Power: 0 Item 9: Aggregate Amount Owned: 1,950,016 Item 10: Check Box If Aggregate Amount Excludes Certain Shares: N/A Item 11: Percent of Class Owned: 7.8% Item 12: Type of Reporting Person: IA Item 1(a): Name of Issuer: Innospec, Inc. Item l(b): Address of Issuer: 8310 South Valley Highway, Ste 350, Englewood, CO 80112 Item 2(a): Name of Person Filing: Wasatch Advisors LP Item 2(b): Address: 505 Wakara Way, Salt Lake City, UT 84108 Item 2(c): Citizenship: Not Applicable Item 2(d): Title of Class of Securities: Common Stock Item 2(e): CUSIP Number: 45768S105 Item 3(e): Investment Adviser registered under section 203 of the Investment Advisers Act of 1940 Item 4(a): Amount Owned: 1,950,016 Item 4(b): Percent of Class Owned: 7.8% Item 4(c)(i): Sole Voting Power: 1,950,016 Item 4(c)(ii): Shared Voting Power: 0 Item 4(c)(iii): Sole Dispositive Power: 1,950,016 Item 4(c)(iv): Shared Dispositive Power: 0 Item 5: Check Box If Ownership Is 5% or Less of Class: [ ] Item 6. Ownership of More Than 5% on Behalf of Another Person: N/A Item 7: Identification of Subsidiary: Not Applicable Item 8: Identification of Members of Group: Not Applicable Item 9: Notice of Dissolution of Group: Not Applicable Item 10: Certification: By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purpose or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct as of December 31, 2023. Date: 02/09/24 Signature: /s/JB Taylor Name/Title: JB Taylor/CEO
    Get the next $IOSP alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $IOSP

    DatePrice TargetRatingAnalyst
    4/21/2025$115.00Neutral → Buy
    Seaport Research Partners
    3/30/2022Neutral
    Seaport Research Partners
    More analyst ratings

    $IOSP
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Innospec Reports First Quarter 2025 Financial Results

      Balanced results considering market volatility Excellent growth in Fuels Specialties offsetting lower results in Performance Chemicals and Oilfield Services $28.3 million cash generated from operations; Net cash improves to $299.8 million Dividend increased by 10 percent; $50 million buyback initiated; Flexible debt-free balance sheet GAAP EPS of $1.31 and adjusted non-GAAP EPS of $1.42 ENGLEWOOD, Colo., May 08, 2025 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ:IOSP) today announced its financial results for the first quarter ended March 31, 2025. The Company declared its semi-annual dividend of 84 cents per common share for the first half of this year, representing an increase of 10 per

      5/8/25 4:45:00 PM ET
      $IOSP
      Major Chemicals
      Industrials
    • Innospec Schedules First Quarter 2025 Earnings Release and Conference Call

      ENGLEWOOD, Colo., April 03, 2025 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ:IOSP) today announced that it will release first quarter 2025 earnings results on Thursday, May 8, 2025 after market close. Following the release of its results, Patrick S. Williams, President and Chief Executive Officer, and Ian Cleminson, Executive Vice President and Chief Financial Officer, will host an interactive conference call on Friday, May 9, 2025, at 9:00 a.m. ET. The public is invited to listen to the conference call by registering in advance using the below Online Registration Link. Upon registering, each participant will receive an email confirmation with dial-in numbers and a unique Personal PIN which

      4/3/25 5:45:00 PM ET
      $IOSP
      Major Chemicals
      Industrials
    • Innospec Approves New $50MM Share Repurchase Program

      ENGLEWOOD, Colo., March 10, 2025 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ:IOSP) today announces that its Board of Directors has approved a new $50 million share repurchase program. The company's prior $50 million share repurchase program expired in the first quarter of 2025. Patrick S. Williams, President and Chief Executive Officer, said, "With over $289 million in net cash, we continue to have significant flexibility and balance sheet strength for further M&A, organic investment, dividend growth and share repurchases under this renewed buyback program." Purchases may be made from time to time at management's discretion. About Innospec Inc. Innospec Inc. is an international special

      3/10/25 4:45:00 PM ET
      $IOSP
      Major Chemicals
      Industrials

    $IOSP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Parrette Leslie J sold $40,421 worth of shares (446 units at $90.63), decreasing direct ownership by 8% to 5,497 units (SEC Form 4)

      4 - INNOSPEC INC. (0001054905) (Issuer)

      5/15/25 9:11:51 PM ET
      $IOSP
      Major Chemicals
      Industrials
    • SVP, HUMAN RESOURCES Griffin Hardy Louis Iii covered exercise/tax liability with 600 shares, decreasing direct ownership by 8% to 6,742 units (SEC Form 4)

      4 - INNOSPEC INC. (0001054905) (Issuer)

      5/15/25 9:05:37 PM ET
      $IOSP
      Major Chemicals
      Industrials
    • SVP, Corporate Dev and IR Barnes Corbin covered exercise/tax liability with 740 shares, decreasing direct ownership by 8% to 8,998 units (SEC Form 4)

      4 - INNOSPEC INC. (0001054905) (Issuer)

      5/15/25 9:01:11 PM ET
      $IOSP
      Major Chemicals
      Industrials

    $IOSP
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Innospec upgraded by Seaport Research Partners with a new price target

      Seaport Research Partners upgraded Innospec from Neutral to Buy and set a new price target of $115.00

      4/21/25 8:30:53 AM ET
      $IOSP
      Major Chemicals
      Industrials
    • Seaport Research Partners initiated coverage on Innospec

      Seaport Research Partners initiated coverage of Innospec with a rating of Neutral

      3/30/22 7:37:48 AM ET
      $IOSP
      Major Chemicals
      Industrials

    $IOSP
    Leadership Updates

    Live Leadership Updates

    See more
    • Innospec Appoints Leslie J. Parrette as Non-Employee Director

      ENGLEWOOD, Colo., Dec. 06, 2021 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ:IOSP) today announced that it has appointed Mr. Leslie J. Parrette as a non-employee director, effective January 1, 2022. Mr. Parrette has 14 years experience in private practice as a corporate and transaction lawyer. He subsequently spent 20 years as General Counsel for public companies in domestic and international markets. Most recently, he served as Senior Vice President, General Counsel, Compliance Officer and Corporate Secretary of Novelis Inc., a leading producer of flat-rolled aluminum products and the world's largest recycler of aluminum. He is Founder and President of One Page Thinking, a data visualizatio

      12/6/21 4:45:00 PM ET
      $IOSP
      Major Chemicals
      Industrials

    $IOSP
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Parrette Leslie J bought $15,135 worth of shares (143 units at $105.84), increasing direct ownership by 3% to 4,734 units (SEC Form 4)

      4 - INNOSPEC INC. (0001054905) (Issuer)

      8/14/24 6:31:38 PM ET
      $IOSP
      Major Chemicals
      Industrials
    • Parrette Leslie J bought $24,867 worth of shares (189 units at $131.57), increasing direct ownership by 4% to 4,591 units (SEC Form 4)

      4 - INNOSPEC INC. (0001054905) (Issuer)

      5/20/24 6:07:17 PM ET
      $IOSP
      Major Chemicals
      Industrials
    • Parrette Leslie J bought $50,824 worth of shares (410 units at $123.96), increasing direct ownership by 13% to 3,620 units (SEC Form 4)

      4 - INNOSPEC INC. (0001054905) (Issuer)

      2/23/24 6:19:14 PM ET
      $IOSP
      Major Chemicals
      Industrials

    $IOSP
    Financials

    Live finance-specific insights

    See more
    • Innospec Reports First Quarter 2025 Financial Results

      Balanced results considering market volatility Excellent growth in Fuels Specialties offsetting lower results in Performance Chemicals and Oilfield Services $28.3 million cash generated from operations; Net cash improves to $299.8 million Dividend increased by 10 percent; $50 million buyback initiated; Flexible debt-free balance sheet GAAP EPS of $1.31 and adjusted non-GAAP EPS of $1.42 ENGLEWOOD, Colo., May 08, 2025 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ:IOSP) today announced its financial results for the first quarter ended March 31, 2025. The Company declared its semi-annual dividend of 84 cents per common share for the first half of this year, representing an increase of 10 per

      5/8/25 4:45:00 PM ET
      $IOSP
      Major Chemicals
      Industrials
    • Innospec Schedules First Quarter 2025 Earnings Release and Conference Call

      ENGLEWOOD, Colo., April 03, 2025 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ:IOSP) today announced that it will release first quarter 2025 earnings results on Thursday, May 8, 2025 after market close. Following the release of its results, Patrick S. Williams, President and Chief Executive Officer, and Ian Cleminson, Executive Vice President and Chief Financial Officer, will host an interactive conference call on Friday, May 9, 2025, at 9:00 a.m. ET. The public is invited to listen to the conference call by registering in advance using the below Online Registration Link. Upon registering, each participant will receive an email confirmation with dial-in numbers and a unique Personal PIN which

      4/3/25 5:45:00 PM ET
      $IOSP
      Major Chemicals
      Industrials
    • Innospec Approves New $50MM Share Repurchase Program

      ENGLEWOOD, Colo., March 10, 2025 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ:IOSP) today announces that its Board of Directors has approved a new $50 million share repurchase program. The company's prior $50 million share repurchase program expired in the first quarter of 2025. Patrick S. Williams, President and Chief Executive Officer, said, "With over $289 million in net cash, we continue to have significant flexibility and balance sheet strength for further M&A, organic investment, dividend growth and share repurchases under this renewed buyback program." Purchases may be made from time to time at management's discretion. About Innospec Inc. Innospec Inc. is an international special

      3/10/25 4:45:00 PM ET
      $IOSP
      Major Chemicals
      Industrials

    $IOSP
    SEC Filings

    See more
    • SEC Form SD filed by Innospec Inc.

      SD - INNOSPEC INC. (0001054905) (Filer)

      5/30/25 6:04:36 AM ET
      $IOSP
      Major Chemicals
      Industrials
    • SEC Form 8-K filed by Innospec Inc.

      8-K - INNOSPEC INC. (0001054905) (Filer)

      5/14/25 6:04:58 AM ET
      $IOSP
      Major Chemicals
      Industrials
    • Amendment: SEC Form SCHEDULE 13G/A filed by Innospec Inc.

      SCHEDULE 13G/A - INNOSPEC INC. (0001054905) (Subject)

      5/13/25 3:37:53 PM ET
      $IOSP
      Major Chemicals
      Industrials

    $IOSP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Innospec Inc. (Amendment)

      SC 13G/A - INNOSPEC INC. (0001054905) (Subject)

      2/13/24 5:06:27 PM ET
      $IOSP
      Major Chemicals
      Industrials
    • SEC Form SC 13G/A filed by Innospec Inc. (Amendment)

      SC 13G/A - INNOSPEC INC. (0001054905) (Subject)

      2/9/24 2:18:58 PM ET
      $IOSP
      Major Chemicals
      Industrials
    • SEC Form SC 13G/A filed by Innospec Inc. (Amendment)

      SC 13G/A - INNOSPEC INC. (0001054905) (Subject)

      1/12/24 8:24:55 AM ET
      $IOSP
      Major Chemicals
      Industrials